Mark Douglas Smith

CIK: 0001756253

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (16.7%)

Position reduction

Option Exercises (M)1 (8.3%)

Derivative conversions

Awards (A)6 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

JAZZ

Jazz Pharmaceuticals plc

Director

PHR

Phreesia, Inc.

Director

TDOC

Teladoc Health, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (12 total)

JAZZ
Jazz Pharmaceuticals plc
Aug 31, 2026
Tax Payment(F)
Direct
1.7K shares at avg. $241.39$408K
JAZZ
Jazz Pharmaceuticals plc
Aug 31, 2026
Tax Payment(F)
Direct
14 shares at avg. $244.64$3K
JAZZ
Jazz Pharmaceuticals plc
Aug 5, 2026
Award(A)
Direct
1.6K shares-
PHR
Phreesia, Inc.
Jun 24, 2026
Award(A)
Direct
19.3K shares at avg. $9.59$185K
JAZZ
Jazz Pharmaceuticals plc
Jun 15, 2026
Sale(S)
Direct
1.2K shares at avg. $230.55$267K
TDOC
Teladoc Health, Inc.
May 21, 2026
Award(A)
Restricted Stock Units
Direct
30.4K shares-
JAZZ
Jazz Pharmaceuticals plc
Aug 8, 2025
Tax Payment(F)
Direct
1.8K shares at avg. $111.25$201K
JAZZ
Jazz Pharmaceuticals plc
Aug 7, 2025
Award(A)
Direct
3.5K shares-
PHR
Phreesia, Inc.
Jul 2, 2025
Sale(S)
Direct
7K shares at avg. $29.00$203K
PHR
Phreesia, Inc.
Jul 2, 2025
Exercise(M)
Direct
7K shares at avg. $4.71$33K
PHR
Phreesia, Inc.
Jun 25, 2025
Award(A)
Direct
6.7K shares at avg. $27.61$185K
TDOC
Teladoc Health, Inc.
May 22, 2025
Award(A)
Restricted Stock Units
Direct
29K shares-

		Type	Shares	Price		Ownership
Aug 31, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	1,692	$241.39	$408,432	Direct
Aug 31, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	14	$244.64	$3,425	Direct
Aug 5, 2026	JAZZ Jazz Pharmaceuticals plc	Award(A)	1,605	-	$0	Direct
Jun 24, 2026	PHR Phreesia, Inc.	Award(A)	19,290	$9.59	$184,991	Direct
Jun 15, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	1,157	$230.55	$266,746	Direct
May 21, 2026	TDOC Teladoc Health, Inc.	Award(A) Restricted Stock Units	30,441	-	-	Direct
Aug 8, 2025	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	1,805	$111.25	$200,807	Direct
Aug 7, 2025	JAZZ Jazz Pharmaceuticals plc	Award(A)	3,507	-	-	Direct
Jul 2, 2025	PHR Phreesia, Inc.	Sale(S)	7,000	$29.00	$203,000	Direct
Jul 2, 2025	PHR Phreesia, Inc.	Exercise(M)	7,000	$4.71	$32,970	Direct
Jun 25, 2025	PHR Phreesia, Inc.	Award(A)	6,700	$27.61	$184,987	Direct
May 22, 2025	TDOC Teladoc Health, Inc.	Award(A) Restricted Stock Units	28,986	-	-	Direct

1-12 of 12 transactions

About Smith Mark Douglas

Smith Mark Douglas (SEC CIK 0001756253) files insider reports with the SEC as Director of Jazz Pharmaceuticals plc (JAZZ), Director of Phreesia, Inc. (PHR) and Director of Teladoc Health, Inc. (TDOC).

Signal8 holds 9 ownership filings by Smith Mark Douglas, all Form 4s, filed between May 23, 2025 and Sep 2, 2026. Those filings report 12 transactions, from May 22, 2025 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Smith Mark Douglas's filings is in DUBLIN 4.

Recent filings by Smith Mark Douglas

Aug 31, 2026: Tax withholdings of JAZZ shares (2 lines, Form 4, code F).
Aug 5, 2026: Grant or award of JAZZ shares (Form 4, code A).
Jun 24, 2026: Grant or award of PHR shares (Form 4, code A).
Jun 15, 2026: Open-market sale of JAZZ shares (Form 4, code S).
May 21, 2026: Grant or award of TDOC derivative securities (Form 4, code A).

Other insiders filing for Jazz Pharmaceuticals plc (JAZZ)

GALA RENEE D, President & CEO
COZADD BRUCE C, Director
Patil Neena M, EVP & Chief Legal Officer
Henderson Mary Elizabeth, SVP, Technical Operations
RIEDEL NORBERT G, Director
LOVE TED W, Director

How to read Form 4 transaction codes